ST
CRL icon

Spot Trading’s Charles River Laboratories CRL Stock Holding History

Spot Trading’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-25,000
Closed -$2.08M – 2821
2016
Q3 		$2.08M Buy
+25,000
New +$2.1M 0.04% 637
2014
Q2 		– Sell
-23,100
Closed -$1.39M – 4590
2014
Q1 		$1.39M Buy
23,100
+16,100
+230% +$938K 0.01% 1777
2013
Q4 		$371K Buy
+7,000
New +$352K ﹤0.01% 2679
2013
Q3 		– Sell
-1,000
Closed -$41K – 4146
2013
Q2 		$41K Buy
+1,000
New +$42.8K ﹤0.01% 3721

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Spot Trading's CRL Position: Q3 2013 in Review

Spot Trading sold out of Charles River Laboratories (CRL) in Q3 2013, closing a stake of 11,178 shares — an estimated $459K sold.

Spot Trading first reported a position in CRL in Q2 2013 and held it in 1 quarter. The position peaked at $459K in Q2 2013. 230 funds tracked by Wall St. Rank hold CRL as of Q3 2013.

  • Spot Trading reported no remaining Charles River Laboratories position as of Q3 2013 after selling out during the quarter.
  • Spot Trading sold 11,178 Charles River Laboratories shares in Q3 2013, an estimated $459K.
  • Spot Trading first reported a position in Charles River Laboratories in Q2 2013 and held it in 1 quarter.
  • Spot Trading's Charles River Laboratories position peaked at $459K in Q2 2013.
  • 230 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2013.

Based on Spot Trading's 13F filing for Q3 2013, filed 8 Nov 2013.